| Literature DB >> 27936886 |
Ruben T H M Larue1, Gilles Defraene2, Dirk De Ruysscher1, Philippe Lambin1, Wouter van Elmpt1.
Abstract
Quantitative analysis of tumour characteristics based on medical imaging is an emerging field of research. In recent years, quantitative imaging features derived from CT, positron emission tomography and MR scans were shown to be of added value in the prediction of outcome parameters in oncology, in what is called the radiomics field. However, results might be difficult to compare owing to a lack of standardized methodologies to conduct quantitative image analyses. In this review, we aim to present an overview of the current challenges, technical routines and protocols that are involved in quantitative imaging studies. The first issue that should be overcome is the dependency of several features on the scan acquisition and image reconstruction parameters. Adopting consistent methods in the subsequent target segmentation step is evenly crucial. To further establish robust quantitative image analyses, standardization or at least calibration of imaging features based on different feature extraction settings is required, especially for texture- and filter-based features. Several open-source and commercial software packages to perform feature extraction are currently available, all with slightly different functionalities, which makes benchmarking quite challenging. The number of imaging features calculated is typically larger than the number of patients studied, which emphasizes the importance of proper feature selection and prediction model-building routines to prevent overfitting. Even though many of these challenges still need to be addressed before quantitative imaging can be brought into daily clinical practice, radiomics is expected to be a critical component for the integration of image-derived information to personalize treatment in the future.Entities:
Mesh:
Year: 2016 PMID: 27936886 PMCID: PMC5685111 DOI: 10.1259/bjr.20160665
Source DB: PubMed Journal: Br J Radiol ISSN: 0007-1285 Impact factor: 3.039
Figure 1.An overview of the radiomics workflow and corresponding topics addressed in this review. PET, positron emission tomography.
Figure 2.Positron emission tomography (PET) radiomic features[14] and their dependency on the delineation method in oesophageal cancer: the 50% maximum standardized uptake value (SUVmax) delineation is used as reference. Fuzzy locally adaptive Bayesian (FLAB) delineation was implemented as described previously.[51]
Overview of currently available software packages for radiomics analysis (August 2016)
| Software package | Imaging modality and format | ROI definition | Features and image pre-processing | Model building | Website |
|---|---|---|---|---|---|
| IBEX (free open source) | CT, PET, MR | DICOM-RT | 109: intensity, texture, shape | Validation of existing models | |
| CGITA (free open source) | Designed for PET; CT, MR tested-DICOM | DICOM-RT, PMOD | 72: intensity, texture | None | |
| MaZda (free open source) | Designed for MR | Thresholding, deformable surface | 279: intensity, texture, shape, wavelet | ANN, clustering Fisher, MI, PCA | |
| RADIOMICS™ (OncoRadiomics, Maastricht, Netherlands) (commercial) | CT, PET, MR | DICOM-RT | 543: intensity, texture, shape, wavelet | None | |
| TexRAD™ (Feedback plc, Cambridge, UK) (commercial) | CT, PET, MR | DICOM-RT | −30: texture and filtering (Laplacian of Gaussian) | Data-mining tool |
ANN, Artificial Neural Network; CGITA, Chang Gung Image Texture Analysis; DICOM, digital imaging and communications in medicine; DICOM-RT, Digital Imaging and Communications in Medicine-Radiation Therapy; FCM, fuzzy c-means; IBEX, imaging biomarker explorer; MI, Mutual Information; PCA, Principal Component Analysis; PET, positron emission tomography; PMOD, PMOD Technologies LLC; ROI, region of interest; TPS, Treatment Planning System.
Their characteristics and functionalities for the four main steps of the radiomics workflow are summarized.